Nirmal Ahuja, Sznajder Kristin, Patil Rajendra, Shaikh Bushra
Harrisburg University of Science and Technology, Harrisburg, PA 17101, United States.
Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA 17033, United States.
J Clin Tuberc Other Mycobact Dis. 2021 Apr 20;23:100234. doi: 10.1016/j.jctube.2021.100234. eCollection 2021 May.
Presently, pills and injections are the two modes of therapeutic treatment available for tuberculosis (TB) patients. Many researchers have hypothesized inhalation drug delivery for reducing treatment times and possibly limiting the insurgence of drug resistance. This study was aimed at identifying and assessing the preferences of inhalation therapy over injections/pills among pulmonary TB patients.
Cross-sectional study design was used and a sample of 477 participants were recruited at selected three Directly Observed Treatment Short-Course (DOTS) centers in Bhiwandi city. Data was collected through self-reported questionnaire. Descriptive statistics were reported, and binomial regression models were applied for data analysis.
The preference of inhalants over pills/injections among pulmonary TB patients was significantly associated with clinical characteristics. The patients who underwent treatment for more than 1 year were 1.7 times more likely to prefer inhalants over pills/injections when compared with treatment duration of less than 1 year. Similarly, patients taking five or more pills/day were 1.7 times more likely to prefer inhalants over pills/injections when compared with patients taking 1-4 pills per day.
The study results signify that inhalants could be an acceptable method of drug delivery in this population of TB patients. Diverse drug delivery options for TB patients may greatly contribute towards TB treatment adherence.
目前,药丸和注射是肺结核(TB)患者可用的两种治疗方式。许多研究人员推测吸入给药可缩短治疗时间,并可能限制耐药性的出现。本研究旨在确定并评估肺结核患者对吸入疗法相对于注射/药丸疗法的偏好。
采用横断面研究设计,在比万迪市选定的三个直接观察短程治疗(DOTS)中心招募了477名参与者作为样本。通过自我报告问卷收集数据。报告描述性统计数据,并应用二项式回归模型进行数据分析。
肺结核患者对吸入剂相对于药丸/注射剂的偏好与临床特征显著相关。与治疗时间少于1年的患者相比,接受治疗超过1年的患者更倾向于选择吸入剂而非药丸/注射剂的可能性高出1.7倍。同样,与每天服用1-4片药丸的患者相比,每天服用5片或更多药丸的患者更倾向于选择吸入剂而非药丸/注射剂的可能性高出1.7倍。
研究结果表明,吸入剂可能是该肺结核患者群体中一种可接受的给药方式。为肺结核患者提供多样化的给药选择可能会极大地有助于提高肺结核治疗的依从性。